BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10849371)

  • 1. The amino acid sequence of a monoclonal gamma 3-heavy chain from a patient with articular gamma-heavy chain deposition disease.
    Danevad M; Sletten K; Gaarder PI; Mellbye OJ; Husby G
    Scand J Immunol; 2000 Jun; 51(6):602-6. PubMed ID: 10849371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
    Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
    Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal IgM cryoglobulinemia associated with gamma-3 heavy chain disease: immunochemical and biochemical studies.
    Wang AC; Arnaud P; Fudenberg HH; Creyssel R
    Eur J Immunol; 1978 Jun; 8(6):375-9. PubMed ID: 97087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of abnormal heavy chains in human heavy-chain-deposition disease.
    Khamlichi AA; Aucouturier P; Preud'homme JL; Cogné M
    Eur J Biochem; 1995 Apr; 229(1):54-60. PubMed ID: 7744049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new case of gamma-3 heavy chain disease. Biochemical and immunological investigations.
    Biewenga J; van Loghem E
    Vox Sang; 1979; 36(4):193-8. PubMed ID: 88813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
    Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
    Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new case of gamma heavy chain disease: clinical, immunochemical and structural characterization.
    Carbonara AO; Paolino W; Malavasi F; Levis A; Stramignoni A; de Lange G; van Loghem E; Franklin EC
    Vox Sang; 1979; 37(2):89-95. PubMed ID: 91266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural heterogeneity among degraded gamma heavy chain disease proteins.
    Franklin EC
    J Immunol; 1978 Dec; 121(6):2582-3. PubMed ID: 102697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
    Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
    J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
    Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
    Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary structure of human gamma 3 immunoglobulin deletion mutant: gamma 3 heavy-chain disease protein Wis.
    Frangione B; Rosenwasser E; Prelli F; Franklin EC
    Biochemistry; 1980 Sep; 19(18):4304-8. PubMed ID: 6774747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of a human gamma 3 myeloma protein (Jir) bearing the allotypic marker Gm(st).
    Matsumoto H; Ito S; Miyazaki T; Ohta T
    J Immunol; 1983 Oct; 131(4):1865-70. PubMed ID: 6413581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystals of the human heavy chain disease protein Riv and human Fc fragment are isomorphous: further evidence for conformational flexibility in the hinge region of immunoglobulins.
    Mariuzza RA; Poljak RJ; Mihaesco C; Mihaesco E
    J Mol Biol; 1983 Apr; 165(3):559-61. PubMed ID: 6405046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of putative monoclonal anti-G3m(u) and anti-G3m(g) reagents and their antigenic determinants.
    Nelson PN; Goodall M; Jefferis R
    Immunol Invest; 1994 Jan; 23(1):39-45. PubMed ID: 7511566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biosynthetic studies of a crystallizable human gamma 1 heavy-chain disease protein.
    Mihaesco E; Guglielmi P; Brouet JC; Mihaesco C
    Scand J Immunol; 1983 Aug; 18(2):145-52. PubMed ID: 6410498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino acid sequence of a human immunoglobulin G3m(g) pFc' fragment.
    Michaelsen TE; Frangione B; Franklin EC
    J Immunol; 1977 Aug; 119(2):558-63. PubMed ID: 407300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
    Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
    Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.